30243J0 – Transfusion of Autologous Serum Albumin into Central Vein, Percutaneous Approach
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
PCS Table
|
Section
3
Administration
|
|||
|
Body System
0
Circulatory
|
|||
|
Operation
2
Transfusion
|
|||
| Body System / Region | Approach | Substance | Qualifier |
|
3
Peripheral Vein
4
Central Vein
|
3
Percutaneous
|
A
Stem Cells, Embryonic
|
Z
No Qualifier
|
|
3
Peripheral Vein
4
Central Vein
|
3
Percutaneous
|
C
Hematopoietic Stem/Progenitor Cells, Genetically Modified
|
0
Autologous
|
|
3
Peripheral Vein
4
Central Vein
|
3
Percutaneous
|
D
Pathogen Reduced Cryoprecipitated Fibrinogen Complex
|
1
Nonautologous
|
|
3
Peripheral Vein
4
Central Vein
|
3
Percutaneous
|
G
Bone Marrow
X
Stem Cells, Cord Blood
Y
Stem Cells, Hematopoietic
|
0
Autologous
2
Allogeneic, Related
3
Allogeneic, Unrelated
4
Allogeneic, Unspecified
|
|
3
Peripheral Vein
4
Central Vein
|
3
Percutaneous
|
H
Whole Blood
J
Serum Albumin
K
Frozen Plasma
L
Fresh Plasma
M
Plasma Cryoprecipitate
N
Red Blood Cells
P
Frozen Red Cells
Q
White Cells
R
Platelets
S
Globulin
T
Fibrinogen
V
Antihemophilic Factors
W
Factor IX
|
0
Autologous
1
Nonautologous
|
|
3
Peripheral Vein
4
Central Vein
|
3
Percutaneous
|
U
Stem Cells, T-cell Depleted Hematopoietic
|
2
Allogeneic, Related
3
Allogeneic, Unrelated
4
Allogeneic, Unspecified
|
|
7
Products of Conception, Circulatory
|
3
Percutaneous
7
Via Natural or Artificial Opening
|
H
Whole Blood
J
Serum Albumin
K
Frozen Plasma
L
Fresh Plasma
M
Plasma Cryoprecipitate
N
Red Blood Cells
P
Frozen Red Cells
Q
White Cells
R
Platelets
S
Globulin
T
Fibrinogen
V
Antihemophilic Factors
W
Factor IX
|
1
Nonautologous
|
|
8
Vein
|
3
Percutaneous
|
B
4-Factor Prothrombin Complex Concentrate
|
1
Nonautologous
|